CST6

CST6

Target · Cysteine protease inhibitor

CST6 Cystatin E/M · Cystatin-M

CST6 (cystatin E/M) is a secreted type 2 cystatin that acts as a high-affinity inhibitor of the cysteine proteases cathepsin L, cathepsin V and legumain. It is also known by its UniProt name, cystatin-M, and has been linked to epidermal and hair follicle biology. Browse Assay Genie's current range of CST6 research reagents below, or read on for the biology behind the target.

Secreted proteinCysteine protease inhibitorDown-regulated in metastasis
149 aa
Protein length
~17 kDa
Molecular weight
11q13.1
Gene locus
Type 2 cystatin
Protein family
Target information

What is CST6 (cystatin E/M)?

CST6 functions as a high-affinity inhibitor of cathepsin L, cathepsin L2 (also called cathepsin V) and legumain. By restraining these proteases, the secreted CST6 protein is involved in the regulation of epidermal cornification, and in hair follicle morphogenesis and maintenance.

The CST6 gene encodes a member of the type 2 cystatin family, and UniProt places the protein in the wider cystatin family. HGNC classes it in the gene group Cystatins, type 2. The cystatin superfamily contains proteins with multiple cystatin-like sequences. Some members are active cysteine protease inhibitors, while others have lost, or perhaps never acquired, this activity. The superfamily has three inhibitory families: the type 1 cystatins (stefins), the type 2 cystatins and the kininogens. Type 2 cystatins are cysteine proteinase inhibitors found in a variety of human fluids and secretions, where they appear to provide protective functions.

CST6 has also attracted attention in cancer research. According to the NCBI Gene summary, expression is down-regulated in metastatic breast tumour cells compared with primary tumour cells, and loss of expression is likely associated with progression from a primary tumour to a metastatic phenotype. The HGNC approved name is cystatin E/M. The mouse and rat orthologues listed for this gene are both named Cstb.

Breast cancer progression

CST6 expression is down-regulated in metastatic breast tumour cells relative to primary tumour cells, making it a candidate marker for studying metastatic progression.

Protease inhibition studies

CST6 inhibits cathepsin L, cathepsin V and legumain with high affinity, so it is used to examine control of cysteine protease activity.

Epidermal cornification

CST6 is involved in regulating epidermal cornification, providing an entry point for research on skin barrier formation and maintenance.

Hair follicle biology

CST6 contributes to hair follicle morphogenesis and maintenance, which makes it relevant to studies of follicle development.

Background

CST6 frequently asked questions

What does CST6 do?

CST6 is a secreted inhibitor of cysteine proteases. It binds cathepsin L, cathepsin L2 (cathepsin V) and legumain with high affinity. It is also involved in regulating epidermal cornification and in hair follicle morphogenesis and maintenance.

What other names does CST6 go by?

The HGNC approved name is cystatin E/M, and UniProt lists the protein as cystatin-M. No other aliases or previous symbols are recorded. CST6 belongs to the type 2 cystatins, a group of cysteine proteinase inhibitors found in human fluids and secretions.

Is CST6 linked to cancer?

The NCBI Gene summary reports that CST6 is down-regulated in metastatic breast tumour cells compared with primary tumour cells. Loss of expression is likely associated with progression from a primary tumour to a metastatic phenotype. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other cystatin family members and cystatin-like proteins involved in cysteine protease regulation.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15828; product specifications from Assay Genie datasheets.

CST6 Product listing